Figure 2From: Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy Kaplan-Meier disease-free survival curves according to cyclooxygenase-2 expression. Platinum-based chemotherapy: log-rank, Pā=ā0.017.Back to article page